Boston Scientific valuation

BSX · NYSE · USD

Compare Boston Scientific
$43.03Change from previous close: −1.51%Absolute change: −$0.66

Close · November 17, 2026

Valuation

The P/E ratio is 18.4. The average price target of 28 analysts is $49.60.

Data as of November 17, 2026

Boston Scientific compared with similar companies

Boston Scientific's P/E (trailing 12 months): 18.4, −40% against the median of a group of 11 similar companies (30.5).

Boston Scientific's metrics compared with similar companies
MetricBoston ScientificMedian25th–75th percentileBand
P/E (trailing 12 months)18.430.524.4 – 36.6Low
Forward P/E14.018.415.4 – 23.4Low
EV/EBITDA13.516.114.0 – 19.3Low
Price/book2.473.652.90 – 6.03Low
Price/sales3.013.863.08 – 5.23Low
Gross margin68.0%65.7%60.3% – 68.7%Middle
Operating margin19.6%19.2%16.2% – 22.0%Middle
Net margin16.6%13.4%10.0% – 14.6%High
ROE14.1%11.6%10.0% – 18.0%Middle
Debt/equity0.460.550.37 – 0.63Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Boston Scientific: valuation over time

On the latest fiscal year's earnings (2025), Boston Scientific's P/E today is 22.3, below the median of its last 8 fiscal years (57.8; between 13.6 and 102.8 from 2016 to 2025). Relative to earnings, the stock costs less than it used to.

Boston Scientific P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$95.35$1.9449.1
2024$89.32$1.2571.5
2023$57.81$1.0754.0
2022$46.27$0.45102.8
2021$42.48$0.6961.6
2020$35.95-$0.08—
2019$45.22$3.3313.6
2018$35.34$1.1929.7
2017$24.79$0.08—
2016$21.63$0.2586.5

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$63.33B
Enterprise value
$74.91B
PEG
0.75
EV/revenue
3.56

Profitability and growth

ROA
5.9%
ROIC
7.0%
Revenue growth (year over year)
1.4%
Earnings growth (year over year)
-21.5%

Financial health

Total cash
$609M
Total debt
$11.95B
Current ratio
1.37
Quick ratio
0.62
Altman Z-Score
4.24
Piotroski F-Score
5.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$49.60
Median price target
$49.00
High price target
$60.00
Low price target
$41.00
Analysts with a price target
28
Consensus
Buy
Forward EPS
$3.13
EPS estimate, current year
$3.17

Shares and trading

Beta
0.59
Average volume
19.62M
Shares outstanding
1.45B
Float
1.44B
Institutional ownership
96.9%
Insider ownership
0.3%
Short interest (% of float)
2.4%
Short ratio (days)
1.90